Screener
Immunome IMNM Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Immunome’s reported figures.
Based on trailing twelve months.
The source filing: Immunome’s 10-Q, filed May 12, 2026. Open the filing →
- Filed
- May 12, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219425
FAQ
- What is Immunome's net margin?
- Immunome (IMNM) reported net margin of -5,593.8% in Q1 2026.
- How has Immunome's net margin changed year-over-year?
- Immunome's net margin decreased by 198.3% year-over-year, from -1,875.2% to -5,593.8%.
- What is the long-term trend for Immunome's net margin?
- Over 2 years (2023 to 2025), Immunome's net margin has grown at a 100.4% compound annual growth rate (CAGR), from -761.9% to -3,060%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Immunome's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude